Table 8.
Follow-up PSA analysis stratified by D’Amico Risk (low, medium and high)
| D’Amico Risk | Low | Medium | High |
|---|---|---|---|
| Radiotherapy treatment/ADT (n=49) | 3 | 34 | 12 |
| Rate | 6.1% | 69.4% | 24.5% |
| Mean postoperative time when therapy started (months) | 44 | 16 | 11 |
|
| |||
| BCR (n=28) | 1 | 21 | 6 |
| Rate | 3.6% | 75.0% | 21.4% |
| Mean postoperative time when BCR diagnosed (months) | 3 | 21 | 23 |
|
| |||
| Early salvage radiotherapy (n=14) | 3 | 7 | 4 |
| Rate | 21.4% | 50.0% | 28.6% |
| Mean postoperative time when therapy started (months) | 44 | 19 | 8 |
|
| |||
| PSA >0.1 at first visit (n=36) | 5 | 20 | 11 |
| Rate | 13.9% | 55.6% | 30.5% |
ADT: androgen deprivation therapy; PSA: prostate-specific antigen; BCR: biochemical recurrence.